Antipsychotic add-on falls off FDA measure

Share this article:
Sen. Herb Kohl (D-WI)
Sen. Herb Kohl (D-WI)


The Senate failed to approve legislation meant to enhance antipsychotic regulations in nursing homes, despite passing the bill to which it was attached.

Sens. Herb Kohl (D-WI), Charles Grassley (R-IA) and Richard Blumenthal (D-CT) proposed a regulation that would have standardized protocols for obtaining informed consent before administering antipsychotics for off-label use. The legislation was proposed as an amendment to an existing Food and Drug Administration reauthorization bill (S. 3187), which passed the Senate by  a nearly unanimous 96-1 vote.

“We need a new policy that helps to ensure that these drugs are being appropriately used to treat people with mental illnesses, not used to curb behavioral symptoms of Alzheimer's or other dementias,” Kohl said.

About 1 in 7 residents had at least one Medicare or Medicaid claim for atypical antipsychotics last year, according to the Office of the Inspector General. 



Share this article:

More in News

Long-term care continues to lead in deal volume and value: PwC report

Long-term care continues to lead in deal volume ...

Long-term care bucked healthcare industry trends with strong merger and acquisition activity in the second quarter of 2014, according to newly released data from professional services firm PricewaterhouseCoopers.

Empowering nurse practitioners could reduce hospitalizations from SNFs, study finds

Granting more authority to nurse practitioners is associated with reduced hospitalization of skilled nursing facility residents, according to recently published findings.

Pioneer ACO drops out of program, despite reductions in skilled nursing utilization

A California healthcare system has become the latest dropout from the Pioneer Accountable Care Organization program, despite reducing skilled nursing facility utilization and improving its readmission rates. Sharp HealthCare announced its decision in a quarterly financial statement released Tuesday.